文献速递先天性心脏病外科心外重症与机械循环支持

2000至2020年婴儿心脏移植患者选择、管理与结局的改善

Improvement in patient selection, management and outcomes in infant heart transplant from 2000 to 2020.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

该研究基于UNOS数据库分析2000至2020年4234例≤1岁心脏移植候选婴儿,按三个年代比较。结果显示等待列表生存和移植后生存均显著改善,但等待时间延长,第三年代婴儿体重更大、肾功能更好、透析/呼吸机/ECMO使用更少,LVAD使用增加。

要点

  • 婴儿心脏移植等待列表生存和移植后生存近20年显著改善
  • 第三年代婴儿等待时间更长(33天 vs 46天 vs 67天,P<0.001)
  • 先天性心脏病和ECMO与更差等待列表生存相关(P<0.05)

核心结论

  • 婴儿心脏移植结局已改善,但等待列表时间延长,需增加供体池、专家共识列表策略和供体利用以进一步改善结局。

研究设计与样本

  • 回顾性队列研究,查询UNOS数据库中2000至2020年≤1岁 listed for heart transplantation 的婴儿,共4234例。
  • 按年代分为3组:Era 1(2000-2006)、Era 2(2007-2013)、Era 3(2014-2020)。
  • 采用非参数检验、卡方检验、Log-Rank检验和Cox比例风险比分析(α=0.05)。

主要发现

  • Era 3婴儿 listed 时体重更大(kg,P<0.001)且肾功能更好(P<0.001)。
  • Era 3婴儿透析(P<0.001)、呼吸机(P<0.001)和ECMO(P<0.001)使用更少。
  • LVAD使用显著增加(P<0.001),但等待列表生存(P=0.154)或移植后生存(P=0.51)无差异。
  • 所有3个年代中,等待列表生存(P<0.001)和移植后生存(P<0.001)均显著改善。
  • 先天性心脏病和ECMO在所有3个年代均与更差等待列表生存相关(P<0.05)。

关键数值与推荐

  • 婴儿年龄≤1岁,2000至2020年 listed for heart transplantation。
  • Era 1:2000-2006;Era 2:2007-2013;Era 3:2014-2020。
  • 主要结局为移植后生存,次要结局包括等待列表死亡率、等待时间和影响生存的因素。

临床怎么用

  • 婴儿心脏移植候选者管理改善,但需关注等待时间延长对结局的潜在影响。
  • 先天性心脏病和ECMO支持的婴儿等待列表生存更差,需优化列表策略。
  • LVAD使用增加未显著改善等待列表或移植后生存,需进一步评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The study's primary outcome was to evaluate if post-transplant survival has improved over the last 2 decades. Secondary outcomes were the infant's waitlist mortality, waitlist time and identifying factors that affected the infant's survival. METHODS: United Network for Organ Sharing (UNOS) database was queried for infants (age ≤ 1) who were listed for heart transplantation between 2000 and 2020. The years were divided into 3 eras (Era 1 2000-2006, Era 2 2007-2013 and Era 3 2014-2020). Non-parametric tests, Chi-Squared, Log-Rank test and Cox-Proportional hazard ratio were used for analysis (α = 0.05). RESULTS: 4234 infants were listed for heart transplants between 2000 and 2020. At the time of listing, Infants in era 3 were more likely to be heavier [in kg (P < 0.001)] and had better renal function (P < 0.001). Additionally, they were less likely to be on dialysis (P < 0.001), on a ventilator (P < 0.001) and on extracorporeal membrane oxygenation (P < 0.001). There has been a significant increase in left ventricular assist device use (P < 0.001), though there was no difference in waitlist (0.154) or post-transplant survival (0.51). In all 3 eras, waitlist survival (P < 0.001) and post-transplant survival (P < 0.001) have improved significantly. Congenital heart disease and extracorporeal membrane oxygenation were associated with worse waitlist survival in all 3 eras (P < 0.05). Infants are now waiting longer on the waitlist (in days) (33 Era 1 vs 46 Era 2 vs 67 Era 3, P < 0.001). CONCLUSIONS: Infant heart transplant outcomes have improved, but they are now waiting longer on the waitlist. Further improvement in increasing the donor pool, expert consensus on listing strategies and donor utilization is needed to improve outcomes.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Endo T, Trivedi J, Kozik D, et al. Improvement in patient selection, management and outcomes in infant heart transplant from 2000 to 2020. Eur J Cardiothorac Surg. 2024. PMID: 39454028. doi:10.1093/ejcts/ezae384

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。